ArticleFrontiers in pharmacology2022

Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design.

Annunziata D'Ercole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.